Your session is about to expire
← Back to Search
Study Summary
This trial is testing the safety and tolerability of a new drug, LY3541105, in healthy and overweight people. Blood tests will be done to see how much of the drug gets into the bloodstream and how long it takes the body to get rid of it. The study will also see if LY3541105 affects body weight.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I am a man who agrees not to donate sperm and to use contraception, or I am a woman who cannot become pregnant.I have diabetes, but it's not just from pregnancy.I have a serious heart condition.You have a body mass index (BMI) in the range of greater than or equal to (>/=) 18.
- Group 1: LY3541105 (Part B)
- Group 2: Placebo (Part B)
- Group 3: Placebo (Part C)
- Group 4: LY3541105 (Part C)
- Group 5: LY3541105 (Part A)
- Group 6: Placebo (Part A)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the maximum capacity of this research initiative?
"Affirmative. Clinicaltrials.gov reveals that this research project, which was posted on May 10th 2022 and most recently updated on September 7th 2022, is actively seeking participants. The trial needs to recruit 160 patients from two distinct sites."
Has the FDA greenlit LY3541105 for use?
"The safety of LY3541105 is rated at a 1, as the Phase 1 trial does not possess substantial evidence to guarantee its efficacy or security."
Is participation in this trial restricted to individuals aged seventy-five and under?
"The age range for inclusion in this medical investigation is between 21 and 65 years of maturity."
Am I eligible to be a participant in this experiment?
"To be admitted into this clinical trial, a person must have an excess of bodyweight and lie between the ages of 21 to 65. About 160 individuals will be accepted for participation."
Are there any openings available to participate in the trial?
"This research endeavour is presently recruiting participants, as reported on clinicaltrials.gov – the study was first announced on May 10th 2022 and has been altered most recently on September 7th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger